Clinical Trial Update: Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring a potential protective role of SGLT-2 inhibitors against chemotherapy-induced cardiotoxicity in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN